Intellepedia - IP News Center | Page 273 of 280

This image depicts a person holding a placard reading GILEAD 1,000 per Pill, Shame. This image is relevant as Gilead had filed for a patent for the same medicine in India for the same price. Click on the image for more information

‘Killead’s Patent Application Killed by the Indian Patent Office!

Gilead Sciences was rejected patent for its blockbuster drug Sofosbuvir, a new Hepatitis C drug by the India Patent Office in a major decision taken on 13 January 2015. The drug is branded under the name Sovaldi. Gilead had priced the drug at US$84,000 for a treatment course, or $1,000 per pill in the US and had received a regulatory approval in US in 2013. The patent application (6087/DELNP/2005) for the drug was opposed by the Indian generic company Natco; Medicines,…

BananaIP Reporter Intellectual Property, Patents January 29, 2015 856Views 0Like

Dr. Kalyan delivers a lecture on “Privacy & IT Act – Relevance to Industry” at Bosch

On the occasion of International Data Privacy Day on January 28th, 2015, Dr. Kalyan was invited by Bosch, a global engineering and electronics major, to deliver a lecture on privacy and its significance for Indian organizations. The provisions of the Indian IT Act was a key element of the discussion. The event was attended by Bosch’s senior personnel in information security and privacy roles . Date : 28/01/2015 [button link="http://www.bosch-india-software.com/en/homepage/rbei_homepage.html" newwindow="yes"] Read more[/button]

BananaIP Reporter Intellectual Property January 28, 2015 523Views 0Like

Dr. Kalyan interviewed by Bar & Bench about Pirates of Bollywood

Dr. Kalyan, Managing Partner, BananaIP , was recently interviewed by Bar & Bench about his latest legal thriller “Pirates of Bollywood”. Commenting on why he chooses to write IP based legal thrillers, Dr. Kalyan said, “ Over the years, I have been working on disseminating IP knowledge through workshops and conferences, books and research papers, writings on SiNApSE blog, IP Radio etc. At one point, I felt spreading knowledge through entertainment could help me take the message far and wide”. Date…

BananaIP Reporter Intellectual Property January 26, 2015 587Views 0Like

This image depicts audience in an indoor auditorium. This image is relevant because it informs us about the 4th Annual Legal Era Conclave 2015 to be held on March 12 and 13, 2015. Click on the image to view full post.

Patents: EVENT- IBC Legal’s 23rd Annual Biotech and Pharmaceutical patenting conference

Date: 24- 25 February 2015 Venue: Munich, Germany Agenda: The event designed to help you protect, maximise and grow your IP assets by getting updates and advice on the more complex aspects of patents. Link: Click here

BananaIP Reporter Intellectual Property January 23, 2015 523Views 0Like

Intellectual Property: EVENT- The Grand Masters 2015- In House Counsel Legal Best Practices Summit

Date and Venue : 20 February 2015- Leela Palace, Mumbai 27 February 2015- Le Meridien, Bangalore Agenda: The event recognizes the best of the In-House Counsel of the country and creates a brainstorming discussion ambience for the next-gen In-House Counsel. Link: Click here

BananaIP Reporter Intellectual Property January 23, 2015 516Views 0Like

Pirates of Bollywood on Copyright Infringement

Here's a sneak peak (possible spoiler) at what Pirates of Bollywood brings to its readers in its court arguments on copyright infringement.. Alluring, isn't it? Read on then. Pirates of Bollywood - Court Arguments on Copyright Infringement- An Excerpt (Chapter 59) Sipping on her coffee, Justice Somaiya said, “Counsels, let us start the rebuttals session. As I indicated earlier, we will not be following the standard procedure, and I will interrupt only, if and when, things get out of…

BananaIP Reporter Copyrights, Intellectual Property January 19, 2015 666Views 0Like

Roche’s backbone rendered brittle by Indian Patent Office

The Chennai Patent Office revoked Hoffmann-La-Roche’s patent on its osteoporosis drug, Bonviva, in response to post grant opposition filed by Indian drug maker, Cipla Global Ltd. The drug in question comprises Ibandronate Sodium, used to treat patients suffering from metastatic cancer, associated skeletal fractures and osteoporosis and also for the treatment and prevention of osteoporosis in post-menopausal women. Osteoporosis is the progressive bone disease caused by decrease in bone mass making bones extremely weak and fragile, leading to increased risk of…

BananaIP Reporter Intellectual Property, Patents January 16, 2015 735Views 0Like

Weekly IP Warm-UP!

GOOGLE V. SPAIN – SPANISH PUBLISHERS SUFFER AS GOOGLE NEWS CLOSES OPERATIONS A new Copyright law which has made it mandatory for Google, Yahoo and other news aggregators to pay licensing fee to all news publishers for using their stories or snippets in Google News, results in Google cutting its operations in Spain. However, the regulation allowed publishers to opt in to Google’s index, and prevent Google from paying licensing fee. COPYRIGHT REGULATION TO ALLOW PRIVATE COPYING; TO FACE IRE…

BananaIP Reporter Copyrights, Media and Entertainment Law, Patents, Trademarks January 14, 2015 721Views 1Like

Terror Attack on the Creative Community

It had not even been a week since year 2015 was ushered in, that the world got to face an agonizing event. The terror attack on Charlie Hebdo’s office and people in Paris on January 7, 2015 is the wrecked Wednesday that has left people all over the world with a sense of agony. While all of us have felt solidarity to the victims on many levels, the fact that a creation of the mind could beget such mindless violence…

BananaIP Reporter General January 13, 2015 691Views 0Like

The image depicts some tablets inside a glass. This image is relevant as Drug Humria was not granted Patent in India. Click on the image for more information

Drug Humira turns Rheumatic for Abbott Biotechnology

The Indian Patent Office on December 31, 2014 set aside its order of granting a Patent to Abbott Biotechnology for its drug, Humira, in light of pre-grant opposition filed by Glenmark Pharmaceuticals. In November, 2003, Abbott had filed a patent application No. 526/DELNP/2005 for its drug named Humira, a formulation of human antibodies for treating Rheumatoid Arthritis. Glenmark filed a pre-grant opposition to this application in September, 2008. Since this was not brought to the notice of the Controller, Patent…

BananaIP Reporter Intellectual Property, Patents January 13, 2015 918Views 0Like

Celebrating 20 Years of IP Excellence

‘Killead’s Patent Application Killed by the Indian Patent Office!

Dr. Kalyan delivers a lecture on “Privacy & IT Act – Relevance to Industry” at Bosch

Dr. Kalyan interviewed by Bar & Bench about Pirates of Bollywood

Patents: EVENT- IBC Legal’s 23rd Annual Biotech and Pharmaceutical patenting conference

Intellectual Property: EVENT- The Grand Masters 2015- In House Counsel Legal Best Practices Summit

Pirates of Bollywood on Copyright Infringement

Roche’s backbone rendered brittle by Indian Patent Office

Weekly IP Warm-UP!

Terror Attack on the Creative Community

Drug Humira turns Rheumatic for Abbott Biotechnology

Connect with Us

BananaIP has been acknowledged as a women-owned enterprise, certified by WEConnect International.

Connect with us